Blood test may personalize esophageal cancer therapy
NCT ID NCT06792786
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study explores whether monitoring tumor DNA in the blood (ctDNA) can help guide treatment for esophageal cancer. Researchers will give patients immunotherapy and chemotherapy, followed by chemoradiotherapy, and track ctDNA levels to see if they predict outcomes. The goal is to improve survival for people with advanced esophageal cancer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Toripalimab, paclitaxel, cisplatin
What this could lead to
If successful, this approach could lead to more personalized and effective treatment for esophageal cancer, potentially improving survival rates.
What could go wrong
This is a small, early-phase study with only 30 participants, so results may not apply to everyone. The treatment involves chemotherapy and immunotherapy, which can cause significant side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Jinhua Municipal Central Hospital
RECRUITINGJinhua, Zhejiang, 321000, China
-
The central Hospital of Lishui City
RECRUITINGLishui, Zhejiang, 323000, China